• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec26
Omeros Corporation Receives FDA Approval for YARTEMLEA®
23:36
Nov18
Omeros Corporation's Q3 Earnings Call Highlights Strategic Partnership with Novo Nordisk
00:12
Nov14
Omeros released FY2025 9 Months Earnings on November 13 After-Market EST, actual revenue USD 0, actual EPS USD -1.4768
00:00
Omeros released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4665 (forecast USD -0.4475)
00:00
Nov6
Omeros to Release FY2025 Q3 Earnings on November 13 After-Market EST, Forecast EPS USD -0.4475
00:05
Oct15
Novo Nordisk Obtains Exclusive Development and Commercialization Rights for Omeros' ZALTENIBART
12:30

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -30.92 M, EPS -0.4665

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.42 M, EPS -0.4339

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -33.46 M, EPS -0.5763

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More